Related Experiment Videos
Thymic enlargement in children
E R Sauter1, R M Arensman, K W Falterman
1Department of Pediatric Surgery, Ochsner Clinic, New Orleans, Louisiana.
Insights
Anterior mediastinal masses in children pose challenges. Malignant thymic tumors are more common in children 18 months and older, necessitating surgical exploration, while younger children benefit from observation and corticosteroids.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Diagnostic Imaging
Background:
- Anterior mediastinal masses in children present diagnostic and therapeutic challenges.
- Limited literature addresses pediatric thymic tumor subtypes and treatment.
- Risk stratification for malignant thymic tumors in pediatric patients is crucial.
Purpose of the Study:
- To identify pediatric patients at significant risk for malignant thymic tumors.
- To differentiate management strategies based on patient age and tumor characteristics.
Main Methods:
- Retrospective review of pediatric patients with anterior mediastinal masses.
- Analysis of clinical presentation, tumor characteristics, and outcomes.
- Correlation of age with tumor malignancy and symptomatology.
Main Results:
- Children under 18 months with benign tumors experienced respiratory distress from tracheal compression.
- Older children (≥18 months) had a 29% incidence of malignant thymic tumors, often asymptomatic.
- Malignant thymic tumors were associated with significantly shorter survival compared to benign tumors.
Conclusions:
- Pediatric patients 18 months and older with thymic tumors have a significant risk of malignancy, warranting surgical exploration.
- Infants younger than 18 months require close follow-up and a trial of corticosteroids, with surgery indicated for enlargement or symptoms.
- Age is a critical factor in determining the optimal management strategy for pediatric anterior mediastinal masses.
Abstract:
The presence of an anterior mediastinal mass in an infant or child is a diagnostic and therapeutic challenge. Few papers in the literature specifically address subtypes of thymic tumors in the pediatric population and their treatment. Our purpose was to determine which children are at significant risk of having a malignant thymic tumor. Four children were younger than 18 months old. Of these, two (50%) had respiratory distress from tracheal compression although all four had benign tumors. Of the 14 older children, only two were symptomatic, both of these from myasthenia gravis rather than the size of the mass compressing surrounding structures. Four of the 14 masses (29%) were malignant although none of the four were symptomatic. Children with benign tumors lived significantly longer than those with malignant tumors. The significant incidence of malignancy in thymic tumors when the patient is 18 months or older necessitates surgical exploration with complete removal of the mass. Children younger than 18 months require close follow-up and a trial of corticosteroids. Surgery is necessary if the mass enlarges or becomes symptomatic.